Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast CancerHeikki Joensuu, Henrik Lindman, Minna Tanner et al.|JAMA Oncology|2017Cited by 95
Adjuvant capesitabine in combination with docetaxel (T), epirubicin (E), and cyclophosphamide (C) in the treatment of early breast cancer (BC): 10-year survival results from the randomized FinXX trial.Heikki Joensuu, Henrik Lindman, Pirkko‐Liisa Kellokumpu‐Lehtinen et al.|Journal of Clinical Oncology|2016Cited by 10